164 related articles for article (PubMed ID: 27213499)
1. Chemotherapy-sparing treatment strategies for follicular lymphoma: current options and future directions.
Ng SY; Abramson JS
Curr Opin Hematol; 2016 Jul; 23(4):371-6. PubMed ID: 27213499
[TBL] [Abstract][Full Text] [Related]
2. Novel Agents Beyond Immunomodulatory Agents and Phosphoinositide-3-Kinase for Follicular Lymphoma.
Chin CK; Nastoupil LJ
Hematol Oncol Clin North Am; 2020 Aug; 34(4):743-756. PubMed ID: 32586578
[TBL] [Abstract][Full Text] [Related]
3. Targeting indolent non-Hodgkin lymphoma.
Leslie LA; Skarbnik AP; Bejot C; Stives S; Feldman TA; Goy AH
Expert Rev Hematol; 2017 Apr; 10(4):299-313. PubMed ID: 28277849
[TBL] [Abstract][Full Text] [Related]
4. Current therapeutic strategies and new treatment paradigms for follicular lymphoma.
Kritharis A; Sharma J; Evens AM
Cancer Treat Res; 2015; 165():197-226. PubMed ID: 25655611
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of microenvironment in follicular lymphoma.
Nowakowski GS; Ansell SM
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):169-73. PubMed ID: 25696851
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory Agents in Follicular Lymphoma.
Ysebaert L; Morschhauser F
Hematol Oncol Clin North Am; 2020 Aug; 34(4):715-726. PubMed ID: 32586576
[TBL] [Abstract][Full Text] [Related]
7. An analysis of genetic targets for guiding clinical management of follicular lymphoma.
Alonso-Alonso R; Rodriguez M; Morillo D; Cordoba R; Piris MA
Expert Rev Hematol; 2020 Dec; 13(12):1361-1372. PubMed ID: 33176509
[No Abstract] [Full Text] [Related]
8. Follicular lymphoma: expanding therapeutic options.
Ganti AK; Bociek RG; Bierman PJ; Enke CA; Vose JM; Armitage JO
Oncology (Williston Park); 2005 Feb; 19(2):213-28; discussion 228, 233-6, 239. PubMed ID: 15770890
[TBL] [Abstract][Full Text] [Related]
9. Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategies.
Seiler T; Hiddemann W; Dreyling M
Immunotherapy; 2009 Nov; 1(6):1015-24. PubMed ID: 20635916
[TBL] [Abstract][Full Text] [Related]
10. [Research Advances of Immunotherapy for Follicular Lymphoma --Review].
Qiu LH; Zheng YX; Zheng ZR; Tian C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):627-630. PubMed ID: 35396008
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol-3-Kinase Inhibition in Follicular Lymphoma.
Lynch RC; Gopal AK
Hematol Oncol Clin North Am; 2020 Aug; 34(4):727-741. PubMed ID: 32586577
[TBL] [Abstract][Full Text] [Related]
12. New agents in follicular lymphoma.
Cheson BD
Best Pract Res Clin Haematol; 2011 Jun; 24(2):305-12. PubMed ID: 21658626
[TBL] [Abstract][Full Text] [Related]
13. [Current treatment strategies for follicular lymphoma].
Hiddemann W; Hoster E; Schmidt C; Dreyling M; Unterhalt M
Internist (Berl); 2016 Mar; 57(3):222-9. PubMed ID: 26842683
[TBL] [Abstract][Full Text] [Related]
14. Update on front-line therapy for follicular lymphoma: chemo-immunotherapy with rituximab and survival.
Turturro F
Expert Rev Anticancer Ther; 2007 Jul; 7(7):959-65. PubMed ID: 17627454
[TBL] [Abstract][Full Text] [Related]
15. Targeted Therapies for Follicular Lymphoma.
Girard J; Karimi Y; Carty S; Wilcox R; Kaminiski M; Malek S; Phillips T
Curr Hematol Malig Rep; 2021 Feb; 16(1):25-31. PubMed ID: 33754292
[TBL] [Abstract][Full Text] [Related]
16. Indolent lymphomas: current and emerging treatment approaches.
Maloney D; Kahl BS; Dreyling M
Clin Adv Hematol Oncol; 2006 Sep; 4(9 Suppl 20):1-10; quiz 11-2. PubMed ID: 17139243
[TBL] [Abstract][Full Text] [Related]
17. Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma.
Matsuki E; Younes A
Curr Treat Options Oncol; 2016 Jun; 17(6):31. PubMed ID: 27193488
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-free treatment in patients with follicular lymphoma.
Sarkozy C; Salles G; Bachy E
Expert Rev Hematol; 2015 Apr; 8(2):187-203. PubMed ID: 25585961
[TBL] [Abstract][Full Text] [Related]
19. Refining the management of relapsed or refractory follicular lymphoma.
Pagel JM; Burke JM; Leslie LA
Clin Adv Hematol Oncol; 2020 Dec; 18 Suppl 20(12):1-24. PubMed ID: 33843893
[TBL] [Abstract][Full Text] [Related]
20. Follicular lymphoma: Update on management and emerging therapies at the dawn of the new decade.
Apostolidis J; Mokhtar N; Al Omari R; Darweesh M; Al Hashmi H
Hematol Oncol; 2020 Aug; 38(3):213-222. PubMed ID: 31891210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]